These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9526144)

  • 1. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
    Rush CR; Kollins SH; Pazzaglia PJ
    Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
    Sevak RJ; Stoops WW; Hays LR; Rush CR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.
    Rush CR; Baker RW
    Exp Clin Psychopharmacol; 2001 Feb; 9(1):59-73. PubMed ID: 11519636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
    Lile JA; Stoops WW; Durell TM; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.
    Heishman SJ; Henningfield JE
    Psychopharmacology (Berl); 1991; 103(4):436-42. PubMed ID: 2062984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users.
    Lile JA; Kelly TH; Hays LR
    Behav Pharmacol; 2010 Feb; 21(1):29-38. PubMed ID: 19949319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Rush CR; Baker RW; Rowlett JK
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):22-36. PubMed ID: 10743902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam attenuates the behavioral effects of d-amphetamine in humans.
    Rush CR; Stoops WW; Wagner FP; Hays LR; Glaser PE
    J Clin Psychopharmacol; 2004 Aug; 24(4):410-20. PubMed ID: 15232333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar discriminative-stimulus effects of D-amphetamine in women and men.
    Vansickel AR; Lile JA; Stoops WW; Rush CR
    Pharmacol Biochem Behav; 2007; 87(2):289-96. PubMed ID: 17561238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and physiological effects of cocaine in humans following triazolam.
    Haga JL; Baker RW; Rush CR
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):383-92. PubMed ID: 14643836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
    Stoops WW; Glaser PE; Fillmore MT; Rush CR
    J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans.
    Rush CR; Essman WD; Simpson CA; Baker RW
    J Clin Psychopharmacol; 2001 Jun; 21(3):273-86. PubMed ID: 11386490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans.
    Bickel WK; Oliveto AH; Kamien JB; Higgins ST; Hughes JR
    J Pharmacol Exp Ther; 1993 Jan; 264(1):360-7. PubMed ID: 8423538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
    Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR
    Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo.
    Smith BJ; Bickel WK
    Drug Alcohol Depend; 2001 Feb; 61(3):249-60. PubMed ID: 11164689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).
    Kollins SH; Shapiro SK; Newland MC; Abramowitz A
    Exp Clin Psychopharmacol; 1998 Nov; 6(4):375-389. PubMed ID: 9861552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal.
    Mintzer MZ; Griffiths RR
    J Psychopharmacol; 2003 Mar; 17(1):17-29. PubMed ID: 12680736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.